Our Knowledge Center
The Knowledge Center is a comprehensive repository of information dedicated to the imaging industry. It offers a wide array of expert articles, cutting-edge research, and practical guides on the latest advancements in imaging technology. Designed for healthcare professionals, this resource hub provides valuable insights and updates to help you stay informed and excel in your field.

Atlantic Health System: Leveraging AI for Opportunistic Screening: Identifying Coronary Artery Calcification on Non-ECG Gated Lung Cancer Screening Chest CT

How AI can spot diseases that doctors aren’t looking for
When 58-year-old Will Studholme ended up in accident and emergency at an NHS hospital in Oxford in 2023 with gastrointestinal symptoms, he wasn’t expecting a diagnosis of osteoporosis.

Using Artificial Intelligence to Semi-Quantitate Coronary Calcium as an ‘Incidentaloma’ on Non-Gated, Non-Contrast CT Scans, A Single-Center Descriptive Study in West Michigan.

Artificial Intelligence in Coronary Artery Calcium Scoring

Opportunistic screening with AI could be a game-changer for preventive cardiology

Non-Alcoholic Fatty Liver Disease, Heart Failure, and Long-Term Mortality: Insights From the National Health and Nutrition Examination Survey
To evaluate the association between non-alcoholic fatty liver disease (NAFLD), heart failure (HF), and all-cause mortality. Both NAFLD and HF are increasing in prevalence due to shared risk factors.

Use of AI opportunistic screening in CT for cardiovascular disease
“We’re finding that when you apply AI to these non-cardiac chest CTs, it’s possible to detect coronary calcifications in patients who may otherwise go unnoticed,” explained Ron Blankstein, MD

Forbes Article: AI In Healthcare: A New Era Of Personalized Patient Care

Nanox Highlighted on TIME’s Best Inventions of 2024 List for its AI Solutions
Nanox AI’s Solutions selected for Special Mention on annual list recognizing the most impactful new products and ideas

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
This new AASLD Guidance document reflects many advances in the field pertinent to any practitioner caring for patients with NAFLD and emphasizes advances in noninvasive risk stratification and therapeutics.

Detection of Moderate Hepatic Steatosis on Portal Venous Phase Contrast-Enhanced CT: Evaluation Using an Automated Artificial Intelligence Tool
Precontrast CT is an established means of evaluating for hepatic steatosis; postcontrast CT has historically been limited for this purpose.